Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dianthus Therapeutics, Inc. /DE/ | Director | Common Stock | 2.72M | $32.6M | $12.00 | Jan 22, 2024 | Indirect |
Dianthus Therapeutics, Inc. /DE/ | Director | Pre-Funded Warrants (Right to Buy) | 1.83M | $22M | $12.00 | Jan 22, 2024 | Indirect |
Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 6.5K | Sep 11, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DNTH | Dianthus Therapeutics, Inc. /DE/ | Jan 22, 2024 | 2 | $40M | 4 | Jan 24, 2024 | Director |
MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 1 | $0 | 4 | Sep 13, 2023 | Director |
MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 0 | $0 | 3 | Sep 13, 2023 | Director |